Clinical Trial Update: A Research Study on How Well Concizumab Works for You if You Have Haemophilia A or B With or Without Inhibitors [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating concizumab for Hemophilia A and Hemophilia B with or without inhibitors; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Concizumab (concizumab)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Haemophilia A and B With and Without Inhibitors | Phase 3 | Status: ACTIVE_NOT_RECRUITING